Matthew J. Maurer

2004–2025 年に発表

227
論文数
30,483
被引用数
85
h 指数
209
i10 指数

被引用数

Matthew J. Maurer の年別被引用数1996 年: 被引用 1 件1999 年: 被引用 1 件2004 年: 被引用 3 件2005 年: 被引用 4 件2006 年: 被引用 36 件2007 年: 被引用 36 件2008 年: 被引用 40 件2009 年: 被引用 51 件2010 年: 被引用 63 件2011 年: 被引用 70 件2012 年: 被引用 65 件2013 年: 被引用 70 件2014 年: 被引用 107 件2015 年: 被引用 155 件2016 年: 被引用 163 件2017 年: 被引用 230 件2018 年: 被引用 247 件2019 年: 被引用 957 件2020 年: 被引用 1,272 件2021 年: 被引用 1,389 件2022 年: 被引用 1,171 件2023 年: 被引用 867 件2024 年: 被引用 1,802 件2025 年: 被引用 858 件2026 年: 被引用 21 件1997〜1998 年は被引用が無いため表示していません2000〜2003 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,502 件、この内訳の 26.7%イギリス: 引用元論文 985 件、この内訳の 7.5%イタリア: 引用元論文 975 件、この内訳の 7.4%ドイツ: 引用元論文 712 件、この内訳の 5.4%中国: 引用元論文 695 件、この内訳の 5.3%フランス: 引用元論文 600 件、この内訳の 4.6%カナダ: 引用元論文 542 件、この内訳の 4.1%スペイン: 引用元論文 481 件、この内訳の 3.7%オランダ: 引用元論文 447 件、この内訳の 3.4%日本: 引用元論文 377 件、この内訳の 2.9%オーストラリア: 引用元論文 335 件、この内訳の 2.5%スイス: 引用元論文 325 件、この内訳の 2.5%
0%26.7%その他 24%

分野

  • Medicine60.2%
  • Biochemistry, Genetics and Molecular Biology33.5%
  • Immunology and Microbiology2.3%
  • Engineering1.2%
  • Health Professions0.4%
  • Economics, Econometrics and Finance0.3%
  • その他2.1%

トピック

  • Amyloidosis: Diagnosis, Treatment, Outcomes6.9%
  • Lymphoma Diagnosis and Treatment6.8%
  • CAR-T cell therapy research4.5%
  • Cardiovascular Function and Risk Factors3.4%
  • Cardiomyopathy and Myosin Studies2.8%
  • Parathyroid Disorders and Treatments2.5%
  • その他73.1%

共著者

全論文

検索で開く
  1. Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy

    著者: , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2018 被引用: 2,709

  2. Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Emeline M. Van Craenenbroeck, Miloš Kubánek, David Zemánek, Morten K. Jensen, Jens Mogensen, Jens Jakob Thune, Philippe Charron, Albert Hagège, Olivier Lairez, Jean‐Noël Trochu, Christoph Axthelm, H DUENGEN, Norbert Frey, Veselin Mitrović, Michael R. Preusch, Jeanette Schulz‐Menger, Tim Seidler, Michael Arad, Majdi Halabi, Amos Katz, Daniel Monakier, Offir Paz, Samuel Viskin, Donna R. Zwas, Iacopo Olivotto, Hans‐Peter Brunner‐La Rocca, Michelle Michels, Dariusz Dudek, Zofia Oko‐Sarnowska, Artur Oręziak, Wojciech Wojakowski, Nuno Cardim, Helder Pereira, Roberto Barriales‐Villa, Pablo García Pavía, Juan Gimeno Blanes, Rafael Hidalgo Urbano, Luis Miguel Rincón Diaz, Perry Elliott, Zaheer Yousef, Theodore P. Abraham, Kia Afshar, Paulino Álvarez, Richard G. Bach, Richard C. Becker, Lubna Choudhury, David Fermin, Daniel Jacoby, John L. Jefferies, Christopher M. Kramer, Neal K. Lakdawala, Steven J. Lester, Ali J. Marian, Ahmad Masri, Matthew J. Maurer, Sherif F. Nagueh, Anjali Owens, David S. Owens, Florian Rader, Sara Saberi, Mark V. Sherrid, Jamshid Shirani, John D. Symanski, Aslan T. Turer, Andrew Wang, Omar Wever‐Pinzon, Matthew T. Wheeler, Timothy C. Wong, Mohamad H. Yamani - The Lancet 2020 被引用: 1,210

  3. Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases

    著者: , , , , , , , , , , , , , , , , , , , , , , , - European Heart Journal 2021 被引用: 1,145

  4. Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Claudio Rapezzi, Philip N. Hawkins - Circulation 2016 被引用: 2,011

  5. Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study

    著者: , , , , , , , , , , , , , , , , - Blood 2017 被引用: 1,683

  6. 2023 ACC Expert Consensus Decision Pathway on Comprehensive Multidisciplinary Care for the Patient With Cardiac Amyloidosis

    著者: , , , , , , , , , , , , - Journal of the American College of Cardiology 2023 被引用: 569

  7. Multimorbidity in Older Adults With Cardiovascular Disease

    著者: , , , , , , , , , , - Journal of the American College of Cardiology 2018 被引用: 479

  8. Brexucabtagene Autoleucel for Relapsed or Refractory Mantle Cell Lymphoma in Standard-of-Care Practice: Results From the US Lymphoma CAR T Consortium

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2023 被引用: 176

  9. Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology W orking G roup on M yocardial and P ericardial D iseases

    著者: , , , , , , , , , , , , , , , , , , , , , , , - European Journal of Heart Failure 2021 被引用: 333

  10. Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study

    著者: , , , , , , , , , , , - Journal of Clinical Oncology 2015 被引用: 844

  11. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 1 of 2—Evidence Base and Standardized Methods of Imaging

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Circulation Cardiovascular Imaging 2019 被引用: 475

  12. Dose-Adjusted EPOCH-R Compared With R-CHOP as Frontline Therapy for Diffuse Large B-Cell Lymphoma: Clinical Outcomes of the Phase III Intergroup Trial Alliance/CALGB 50303

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2019 被引用: 423

  13. Characterization of the Inflammatory-Metabolic Phenotype of Heart Failure with a Preserved Ejection Fraction: A Hypothesis to Explain Influence of Sex on the Evolution and Potential Treatment of the Disease

    著者: , , , , - European Journal of Heart Failure 2020 被引用: 174

  14. Multicenter Study of Planar Technetium 99m Pyrophosphate Cardiac Imaging

    著者: , , , , , , , , , , , , , , - JAMA Cardiology 2016 被引用: 420

  15. Cardiac Amyloidosis Due to Transthyretin Protein

    著者: , - JAMA 2024 被引用: 207

  16. Pathophysiology and Therapeutic Approaches to Cardiac Amyloidosis

    著者: , , - Circulation Research 2021 被引用: 189

  17. Event-Free Survival at 24 Months Is a Robust End Point for Disease-Related Outcome in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy

    著者: , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2014 被引用: 410

  18. Transthyretin Stabilization by AG10 in Symptomatic Transthyretin Amyloid Cardiomyopathy

    著者: , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2019 被引用: 255

  19. Deprescribing in Older Adults With Cardiovascular Disease

    著者: , , , , , , , , , , - Journal of the American College of Cardiology 2019 被引用: 204

  20. Cardiac Scintigraphy With Technetium-99m-Labeled Bone-Seeking Tracers for Suspected Amyloidosis

    著者: , , , , , , , , , , - Journal of the American College of Cardiology 2020 被引用: 246

  21. Cost-Effectiveness of Tafamidis Therapy for Transthyretin Amyloid Cardiomyopathy

    著者: , , , , , , , , , , - Circulation 2020 被引用: 246

  22. Addressing Common Questions Encountered in the Diagnosis and Management of Cardiac Amyloidosis

    著者: , , , , - Circulation 2017 被引用: 486

  23. Gerotechnology for Older Adults With Cardiovascular Diseases

    著者: , , , , , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2020 被引用: 116

  24. Screening for Cardiac Amyloidosis 5 to 15 Years After Surgery for Bilateral Carpal Tunnel Syndrome

    著者: , , , , , , , , , - Journal of the American College of Cardiology 2022 被引用: 90